This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Manufacturing Services

Pharmaceutical Development

Our comprehensive service offering includes early stage formulation and analytical development, API capsule and vial filling using Xcelodose® technology, scale-up and stability testing, process validation, technology transfer and all associated analytical support services.

Our strength lies in the integrated nature of our services, combining formulation development and analytical services with clinical trial supplies.

PCI provide CMC Consultancy services to generate the optimum development strategy for your product. By involving our experts early in the strategic development of your new product, we can assist in optimizing the process, ensure that regulatory hurdles are minimized and that the most efficient routes to clinic are delivered.

We are able to offer formulation development services for a variety of dosage forms including:

  • Tablets, capsules and powders
  • Gels and creams
  • Liquids, solutions, suspensions and emulsions
  • Suppositories and pessaries
  • Granules for reconstitution
  • Drug in capsule/vial

Our dedicated team of specialists will be happy to discuss any of your Pharmaceutical Development needs. Contact us on +1 779-774-1428 (US) or +44 1495 711 222 (UK) or email sales@pciservices.com


Expansion of High Potent Tableting and Powder Modification Capacity

Investment in new technologies at PCI’s global manufacturing Center of Excellence in Tredegar, Wales, to double highly potent tableting capacity... View Article

PCI Welcomes New Chief Financial Officer and SVP, Serge Dupuis

PCI is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer. Serge’s appointment supports PCI’s continued... View Article

x